Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1222-1227

  Tirkkonen, Mika ^a   Johannsson, Oskar ^b   Agnarsson, Bjarni A ^c   Olsson, Håkan ^b   Ingvarsson, Sigurdur ^c   Karhu, Ritva ^a   Tanner, Minna ^a   Isola, Jorma ^a   Barkardottir, Rosa B ^c   Borg, Åke ^b   Kallioniemi, Olli P ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 3P; EARLY DIAGNOSIS; EPITHELIUM CELL; GENE ACTIVATION; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SOMATIC CELL GENETICS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 5; DISEASE PROGRESSION; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS;

EID: 0030894785     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Szabo, C. I., and King, M. C. Inherited breast and ovarian cancer. Hum. Mol. Genet., 4: 1811-1817, 1995.
2. Easton, D. F., Bishop, D. T., Ford, D., and Crockford, G. P. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 52: 678-701, 1993.
3. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ormiston, W., McManus, R., Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A. J., Skolnick, M. A., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington DC), 265: 2088-2090, 1994.
4. Lynch, H. T., Marcus, M. M., Watson, P., Conway, T., Fitzsimmons, M. L., and Lynch, J. F. Genetic epidemiology of cancer, pp. 289-332. Boca Raton, FL: CRC Press, Inc., 1989.
5. Bieche, I., and Lidereau, R. Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14: 227-251, 1995.
6. Devilee, P., and Cornelisse, C. J. Somatic changes in human breast cancer. Biochim. Biophys. Acta, 1198: 113-130, 1994.
7. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Collins, C., Stokke, T., Karhu, R., Kowbel, D., Shadravan, F., Hintz, M., Kuo, W. L., Waldman, F. M., Isola, J. J., Gray, J. W., and Kallioniemi, O-P. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res., 54: 4257-4260, 1994.
8. Kallioniemi, A., Kallioniemi, O-P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91: 2156-2160, 1994.
9. Eisinger, F., Stoppa Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincent Salomon, A., Jacquemier, J., Birnbaum, D., and Sobol, H. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56: 471-474, 1996.
10. Johannsson, O., Idvall, I., Anderson, C., Borg, Å., Barkardottir, R. B., Egilsson, V., and Olsson, H. Tumor biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer., in press, 1997.
11. Marcus, J., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephensson, L., Salerno, G., Conway, T. A., and Lynch, H. T. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
12. Johannesdottir, G., Gudmundsson, J., Bergthorsson, J., Arason, A., Agnarsson, B. A., Eiriksdottir, G., Johansson, T., Borg, A., Ingvarsson, S., Easton, D. F., Egilsson, V., and Barkardottir, R. B. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res., 56: 3663-3665, 1996.
13. Johannsson, O. T., Ostermeyer, E. A., Håkansson, S., Friedman, L. S., Johansson, U., Sellberd, G., Bröndum-Nielsen, K., Sele, V., Olsson, H., King, M. C., and Borg, A. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am. J. Hum. Genet., 58: 441-450, 1996.
14. Thorlacius, S., Olafsdottir, G., Tryggvadottir, G., Neuhausen, S., Jonasson, J., Tavtigian, S., Tulinius, H., Ögmundsdottir, H., and Eyfjörd, J. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet, 13: 117-129, 1996.
15. Isola, J., DeVries, S., Chu, L., Ghazvini, S., and Waldman, F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am. J. Pathol., 145: 1301-1308, 1994.
16. Kallioniemi, O-P., Kallioniemi, A., Piper, J., Isola, J., Waldman, F. M., Gray, J. W., and Pinkel, D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer, 10: 231-243, 1994.
17. Visakorpi, T., Kallioniemi, A. H., Syvanen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O-P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
18. Piper, J., Rutovitz, D., Sudar, D., Kallioniemi, A., Kaluoniemi, O-P., Waldman, F. M., Gray, J. W., and Pinkel, D. Computer image analysis of comparative genomic hybridization. Cytometry, 19: 10-26, 1995.
19. Hyytinen, E., Visakorpi, T., Kallioniemi, A., Kallioniemi, O-P., and Isola, J. J. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry, 16: 93-99, 1994.
20. Neuhausen, S. L., and Marshall, C. J. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res., 54: 6069-6072, 1994.
21. Castilla, L. H., Couch, F. J., Erdos, M. R., Hoskins, K. F., Calzone, K., Garber, J. E., Boyd, J., Lubin, M. B., Deshano, M. L., Brody, L. C., Collins, F. S., and Weber, B. L. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet., 8: 387-391, 1994.
22. Cornelis, R. S., Neuhausen, S. L., Johannsson, O., Arason, A., Kelsell, D., Ponder, B. A., Tonin, P., Hamann, U., Lindblom, A., Lalle, P., Longy, M., Olah, E., Scherneck, S., Bignon, Y-J., Sobol, H., Chang-Claude, J., Larsson, C., Spurr, N., Borg, Å., Barkardottir, R. B., Narod, S., Devilee, P., and the Breast Cancer Linkage Consortium. High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer, 13: 203-210, 1995.
23. Shao, N., Chai, Y. L., Shyam, E., Reddy, P., and Rao, V. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene, 13: 1-7, 1996.
24. Thompson, A. M., Morris, R. G., Wallace, M., Wyllie, A. H., Steel, C. M., and Carter, D. C. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br. J. Cancer, 68: 64-68, 1993.
25. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
26. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Isola, J., Kuukasjarvi, T., Collins, C., Kowbel, D., Guan, X. Y., Trent, J., Gray, J. W., Meltzer, P., and Kallioniemi, O-P. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res., 56: 3441-3445, 1996.
27. Knudson, A. G., Meadows, A. T., Nichols, W. W., and Hill, R. Chromosomal deletion and retinoblastoma. N. Engl. J. Med., 295: 1120-1123, 1976.
28. Levy, D. B., Smith, K. J., Beazer-Barclay, Y., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Inactivation of both APC alleles in human and mouse tumors. Cancer Res., 54: 5953-5958, 1994.
29. Miyaki, M., Konishi, M., Kikuchi-Yanoshita, R., Enomoto, M., Igari, T., Tanaka, K., Muraoka, M., Takahashi, H., Amada, Y., and Fukayama, M. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res., 54: 3011-3020, 1994.
30. Gudmundsson, J., Johannesdottir, G., Bergthorsson, J. T., Arason, A., Ingvarsson, S., Egilsson, V., and Barkardottir, R. B. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res., 55: 4830-4832, 1995.
31. Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., Ormiston, W., Daly, P. A., Ford, D., Easton, D. F., and Stratum, M. R. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10: 1673-1675, 1995.
32. Thor, A. D., Moore, D. H., Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L. C., Mayall, B. H., and Smith, H. S. Accumulation of the p53 tumor suppressor gene protein: an independent marker or prognosis in breast cancer. J. Natl. Cancer Inst., 84: 845-855, 1992.